Suggestions for regulatory agency approval of second-line systemic therapy for metastatic transitional cell carcinoma.

Authors :: Sonpavde G
Rosenberg JE
Hahn NM
Galsky MD
Bangs R
Sternberg CN
Vogelzang NJ
Source :: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2010 May 01; Vol. 28 (13), pp. e205-7; author reply e208. Date of Electronic Publication: 2010 Feb 16.
Publication Year :: 2010

Subjects :: Carcinoma, Transitional Cell secondary
Evidence-Based Medicine
Humans
Platinum Compounds administration & dosage
Practice Guidelines as Topic
Randomized Controlled Trials as Topic
Treatment Outcome
Urologic Neoplasms pathology
Vinblastine therapeutic use
Antineoplastic Agents, Phytogenic therapeutic use
Antineoplastic Combined Chemotherapy Protocols therapeutic use
Carcinoma, Transitional Cell drug therapy
Drug Approval
Urologic Neoplasms drug therapy
Vinblastine analogs & derivatives

Language :: English
ISSN :: 1527-7755
Volume :: 28
Issue :: 13
Database :: MEDLINE
Journal :: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Publication Type :: Report
Accession number :: 20159797
Full Text :: https://doi.org/10.1200/JCO.2009.27.1114

Full Text Access

Tools